GAJOFATTO, Alberto
 Distribuzione geografica
Continente #
EU - Europa 230
NA - Nord America 134
AS - Asia 124
AF - Africa 4
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 496
Nazione #
US - Stati Uniti d'America 134
IT - Italia 77
VN - Vietnam 56
CN - Cina 49
FR - Francia 41
DE - Germania 35
GB - Regno Unito 22
IE - Irlanda 20
UA - Ucraina 6
CZ - Repubblica Ceca 5
JP - Giappone 5
RU - Federazione Russa 5
SG - Singapore 5
ES - Italia 4
EG - Egitto 3
SE - Svezia 3
SI - Slovenia 3
AT - Austria 2
CL - Cile 2
IN - India 2
KR - Corea 2
MK - Macedonia 2
TR - Turchia 2
A1 - ???statistics.table.value.countryCode.A1??? 1
BR - Brasile 1
DK - Danimarca 1
GR - Grecia 1
MD - Moldavia 1
NL - Olanda 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
SD - Sudan 1
TW - Taiwan 1
Totale 496
Città #
Dong Ket 44
Ann Arbor 24
Southend 21
Dublin 20
Verona 14
University Park 13
Houston 11
Ashburn 9
Woodbridge 9
Changsha 8
Wilmington 8
Beijing 7
Fairfield 7
Mountain View 7
Lake Forest 6
Fleming Island 5
Guangzhou 5
Columbus 4
Hangzhou 4
Milan 4
Wuhan 4
Cambridge 3
Changchun 3
Ankara 2
Buffalo 2
Catanzaro 2
Chions 2
Haikou 2
Harbin 2
Hiro-oshingai 2
Meieki 2
Nürnberg 2
Rome 2
Ruvo di Puglia 2
Santiago 2
Simi Valley 2
Summonte 2
Udine 2
Zafferana Etnea 2
Aprilia 1
Brescia 1
Bryansk 1
Bussolengo 1
Catania 1
Chaoyang 1
Chengdu 1
Cheyenne 1
Chisinau 1
Cittadella 1
Collegno 1
Corigliano Calabro 1
Council Bluffs 1
Dobrzeszow 1
Le Pré-saint-gervais 1
Leawood 1
Logroño 1
Madrid 1
Mumbai 1
Munich 1
Nablus 1
Nanjing 1
Orange 1
Ozegna 1
Pietra Ligure 1
Pontirolo Nuovo 1
Pordenone 1
Roverbella 1
San Martino Buon Albergo 1
Sarzana 1
Seattle 1
Seoul 1
Shanghai 1
Shenyang 1
Spezzano Albanese 1
Stockholm 1
São Paulo 1
Taipei 1
Tokyo 1
Torino 1
Vicenza 1
Zaragoza 1
Zhengzhou 1
Totale 315
Nome #
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015, file e14ff6e3-24f1-0209-e053-6605fe0ad24c 103
Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date, file e14ff6e3-f66d-0209-e053-6605fe0ad24c 61
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study), file e14ff6e3-f3c1-0209-e053-6605fe0ad24c 45
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis, file e14ff6e3-3823-0209-e053-6605fe0ad24c 36
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status, file e14ff6e4-0e3f-0209-e053-6605fe0ad24c 32
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder, file e14ff6e4-0891-0209-e053-6605fe0ad24c 29
Characterization of Upper Limb Impairments at Body Function, Activity, and Participation in Persons With Multiple Sclerosis by Behavioral and EMG Assessment: A Cross-Sectional Study, file e14ff6e5-0453-0209-e053-6605fe0ad24c 24
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis, file e14ff6e4-a44b-0209-e053-6605fe0ad24c 23
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study, file e14ff6e3-aa70-0209-e053-6605fe0ad24c 18
Brentuximab vedotin: axonal microtubule's Apollyon, file e14ff6e3-26a9-0209-e053-6605fe0ad24c 17
An exploratory panel of cerebrospinal fluid biomarkers compared to standard diagnostic evaluation in initial demyelinating events suggestive of multiple sclerosis, file e14ff6e2-f1ea-0209-e053-6605fe0ad24c 16
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients, file e14ff6e3-1b55-0209-e053-6605fe0ad24c 15
Insights for fostering resilience in young adults with multiple sclerosis in the aftermath of the COVID-19 emergency: an Italian survey, file e14ff6e5-8cdc-0209-e053-6605fe0ad24c 14
Study protocol on advance care planning in multiple sclerosis (ConCure-SM): intervention construction and multicentre feasibility trial, file e14ff6e5-bce7-0209-e053-6605fe0ad24c 13
Conversion to secondary progressive multiple sclerosis: patient awareness and needs. results from an online survey in Italy and Germany, file e14ff6e4-afab-0209-e053-6605fe0ad24c 12
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis, file e14ff6e4-b781-0209-e053-6605fe0ad24c 12
Promoting participatory research in chronicity: The ESPRIMO biopsychosocial intervention for young adults with multiple sclerosis, file 826f6798-d704-48a3-ba4d-be27fc14f8b9 11
"If you can't control the wind, adjust your sail": tips for post-pandemic benefit finding from young adults living with multiple sclerosis. A qualitative study, file e14ff6e5-a413-0209-e053-6605fe0ad24c 11
Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases, file e14ff6e4-bf06-0209-e053-6605fe0ad24c 10
Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure, file e14ff6e4-d5b2-0209-e053-6605fe0ad24c 8
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study, file e14ff6e6-067c-0209-e053-6605fe0ad24c 2
Totale 512
Categoria #
all - tutte 1090
article - articoli 1060
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 30
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201810 0000 00 00 0415
2018/201946 4228 11 21 012211
2019/202077 19491 84 00 41882
2020/2021102 51140 83 55 641140
2021/202281 191112 711 61 3677
2022/2023105 06712 2924 88 11000
Totale 512